BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 38409485)

  • 1. A comprehensive guide to assess gut mycobiome and its role in pathogenesis and treatment of inflammatory bowel disease.
    Yadav A; Yadav R; Sharma V; Dutta U
    Indian J Gastroenterol; 2024 Feb; 43(1):112-128. PubMed ID: 38409485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut mycobiome: The probable determinative role of fungi in IBD patients.
    Beheshti-Maal A; Shahrokh S; Ansari S; Mirsamadi ES; Yadegar A; Mirjalali H; Zali MR
    Mycoses; 2021 May; 64(5):468-476. PubMed ID: 33421192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota beyond Bacteria-Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD.
    Matijašić M; Meštrović T; Paljetak HČ; Perić M; Barešić A; Verbanac D
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fungi in Gastrointestinal Tracts of Human and Mice: from Community to Functions.
    Li J; Chen D; Yu B; He J; Zheng P; Mao X; Yu J; Luo J; Tian G; Huang Z; Luo Y
    Microb Ecol; 2018 May; 75(4):821-829. PubMed ID: 29110065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?
    Serban DE
    Nutr Clin Pract; 2015 Dec; 30(6):760-79. PubMed ID: 26452390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manipulation of Gut Microbiota as a Key Target for Crohn's Disease.
    Rashed R; Valcheva R; Dieleman LA
    Front Med (Lausanne); 2022; 9():887044. PubMed ID: 35783604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the gut microbiota in the treatment of inflammatory bowel diseases.
    Aggeletopoulou I; Konstantakis C; Assimakopoulos SF; Triantos C
    Microb Pathog; 2019 Dec; 137():103774. PubMed ID: 31586663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
    Nishida A; Nishino K; Sakai K; Owaki Y; Noda Y; Imaeda H
    World J Gastroenterol; 2021 Jun; 27(23):3317-3326. PubMed ID: 34163114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's Disease.
    Hoarau G; Mukherjee PK; Gower-Rousseau C; Hager C; Chandra J; Retuerto MA; Neut C; Vermeire S; Clemente J; Colombel JF; Fujioka H; Poulain D; Sendid B; Ghannoum MA
    mBio; 2016 Sep; 7(5):. PubMed ID: 27651359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobiome and Inflammatory Bowel Disease: Role in Disease Pathogenesis, Current Approaches and Novel Nutritional-based Therapies.
    Hsu C; Ghannoum M; Cominelli F; Martino LD
    Inflamm Bowel Dis; 2023 Mar; 29(3):470-479. PubMed ID: 35851921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues.
    Lee M; Chang EB
    Gastroenterology; 2021 Jan; 160(2):524-537. PubMed ID: 33253681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: fungal alterations in inflammatory bowel diseases.
    Lam S; Zuo T; Ho M; Chan FKL; Chan PKS; Ng SC
    Aliment Pharmacol Ther; 2019 Dec; 50(11-12):1159-1171. PubMed ID: 31648369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review.
    Aldars-García L; Marin AC; Chaparro M; Gisbert JP
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of the gut virome and mycobiome in faecal microbiota transplantation.
    Lam S; Bai X; Shkoporov AN; Park H; Wu X; Lan P; Zuo T
    Lancet Gastroenterol Hepatol; 2022 May; 7(5):472-484. PubMed ID: 35276080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
    Qiao YQ; Cai CW; Ran ZH
    J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizations of the Gut Bacteriome, Mycobiome, and Virome in Patients with Osteoarthritis.
    Chen C; Zhang Y; Yao X; Li S; Wang G; Huang Y; Yang Y; Zhang A; Liu C; Zhu D; Li H; Yan Q; Ma W
    Microbiol Spectr; 2023 Feb; 11(1):e0171122. PubMed ID: 36515546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases.
    Oka A; Sartor RB
    Dig Dis Sci; 2020 Mar; 65(3):757-788. PubMed ID: 32006212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.